M. Morisset , F. Codreanu , C. Astier , R. Olivier , S. Jacquenet , B. Bihain , D.-A. Moneret-Vautrin , G. Kanny
{"title":"Intérêt des allergènes recombinants dans le diagnostic de l’allergie alimentaire","authors":"M. Morisset , F. Codreanu , C. Astier , R. Olivier , S. Jacquenet , B. Bihain , D.-A. Moneret-Vautrin , G. Kanny","doi":"10.1016/j.allerg.2008.01.029","DOIUrl":null,"url":null,"abstract":"<div><p>To date, neither in vitro nor in vivo tests can establish with reliability the diagnosis of food allergy. The availability of recombinant allergens (RA) has led to improvement in the standardization of allergenic extracts and enrichment of natural extracts, resulting in more sensitive screening tests. These biotechnological advances facilitate the diagnostic approach which now rests on an individual reaction profile (component resolved diagnosis) with well-characterized allergens classified on a molecular basis. Development of diagnostic tests using RA or peptides expressing some distinctive epitopes of interest may improve the prediction of severe and/or persistent food allergies and guide the choice of the therapeutic measures that follow.</p></div>","PeriodicalId":92953,"journal":{"name":"Revue francaise d'allergologie et d'immunologie clinique","volume":"48 3","pages":"Pages 242-245"},"PeriodicalIF":0.0000,"publicationDate":"2008-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.allerg.2008.01.029","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise d'allergologie et d'immunologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0335745708000555","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
Abstract
To date, neither in vitro nor in vivo tests can establish with reliability the diagnosis of food allergy. The availability of recombinant allergens (RA) has led to improvement in the standardization of allergenic extracts and enrichment of natural extracts, resulting in more sensitive screening tests. These biotechnological advances facilitate the diagnostic approach which now rests on an individual reaction profile (component resolved diagnosis) with well-characterized allergens classified on a molecular basis. Development of diagnostic tests using RA or peptides expressing some distinctive epitopes of interest may improve the prediction of severe and/or persistent food allergies and guide the choice of the therapeutic measures that follow.